These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3385734)

  • 21. Synthesis and allosteric modulation of the dopamine receptor by peptide analogs of L-prolyl-L-leucyl-glycinamide (PLG) modified in the L-proline or L-proline and L-leucine scaffolds.
    Ferreira da Costa J; Caamaño O; Fernández F; García-Mera X; Sampaio-Dias IE; Brea JM; Cadavid MI
    Eur J Med Chem; 2013 Nov; 69():146-58. PubMed ID: 24013414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices.
    Mulder AH; Braakhuis B; De Regt V; Dijkstra D; Horn AS
    Eur J Pharmacol; 1980 Jun; 64(4):349-55. PubMed ID: 7389827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
    Makman MH; Dvorkin B; Klein PN
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4212-6. PubMed ID: 6213964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology of high-affinity binding of [3H](+/-)2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissue.
    Arana GW; Baldessarini RJ; Lamont JS; Amlicke D; Neumeyer JL
    Biochem Pharmacol; 1983 Oct; 32(19):2873-80. PubMed ID: 6626260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of ascorbate and EDTA on high-affinity binding of 3H-apomorphine and 3H-ADTN to calf caudate membranes.
    Arana GW; Baldessarini RJ; Kula NS
    Neuropharmacology; 1982 Jun; 21(6):601-4. PubMed ID: 6810198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allosteric modulation of the dopamine receptor by conformationally constrained type VI beta-turn peptidomimetics of Pro-Leu-Gly-NH2.
    Vartak AP; Skoblenick K; Thomas N; Mishra RK; Johnson RL
    J Med Chem; 2007 Dec; 50(26):6725-9. PubMed ID: 18052024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of a conformationally restricted dopamine analogue, 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, to receptors on rat brain synaptic membranes.
    Roberts PJ; Woodruff GN; Poat JA
    Mol Pharmacol; 1977 May; 13(3):541-7. PubMed ID: 17829
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis, biological activity, and conformational analysis of peptidomimetic analogues of the Saccharomyces cerevisiae alpha-factor tridecapeptide.
    Zhang YL; Marepalli HR; Lu HF; Becker JM; Naider F
    Biochemistry; 1998 Sep; 37(36):12465-76. PubMed ID: 9730819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and dopamine receptor modulating activity of novel peptidomimetics of L-prolyl-L-leucyl-glycinamide featuring alpha,alpha-disubstituted amino acids.
    Evans MC; Pradhan A; Venkatraman S; Ojala WH; Gleason WB; Mishra RK; Johnson RL
    J Med Chem; 1999 Apr; 42(8):1441-7. PubMed ID: 10212130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformationally restricted deltorphin analogues.
    Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
    J Med Chem; 1992 Oct; 35(21):3956-61. PubMed ID: 1331451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of photoaffinity-labeling ligands of the L-prolyl-L-leucylglycinamide binding site involved in the allosteric modulation of the dopamine receptor.
    Fisher A; Mann A; Verma V; Thomas N; Mishra RK; Johnson RL
    J Med Chem; 2006 Jan; 49(1):307-17. PubMed ID: 16392815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of L-prolyl-L-leucyl-glycinamide.
    Ott MC; Mishra RK; Johnson RL
    Brain Res; 1996 Oct; 737(1-2):287-91. PubMed ID: 8930377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro binding of the very potent and selective D-2 dopamine agonist, [3H]N-0437 to calf caudate membranes.
    Van der Weide J; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1987 Feb; 134(2):211-9. PubMed ID: 3569410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.
    Boehme RE; Ciaranello RD
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3255-9. PubMed ID: 6166945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereospecific binding of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat brain dopamine receptors [proceedings].
    Davis A; Poat JA; Woodruff GN
    Biochem Soc Trans; 1979 Feb; 7(1):147-8. PubMed ID: 437261
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of peptidomimetic ligands of Pro-Leu-Gly-NH(2) as allosteric modulators of the dopamine D(2) receptor.
    Bhagwanth S; Mishra RK; Johnson RL
    Beilstein J Org Chem; 2013; 9():204-14. PubMed ID: 23400263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of agonist stimulated adenylyl cyclase and GTPase activity by L-pro-L-leu-glycinamide and its peptidomimetic analogue in rat striatal membranes.
    Mishra RK; Makman MH; Costain WJ; Nair VD; Johnson RL
    Neurosci Lett; 1999 Jul; 269(1):21-4. PubMed ID: 10821635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioactivities and secondary structures of constrained analogues of human parathyroid hormone: cyclic lactams of the receptor binding region.
    Barbier JR; Neugebauer W; Morley P; Ross V; Soska M; Whitfield JF; Willick G
    J Med Chem; 1997 Apr; 40(9):1373-80. PubMed ID: 9135034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.